Crescent Capital BDC, Inc. (CCAP) P/E Ratio History
Fairly ValuedTrading at 12.0x, near 5Y avg of 13.5x · 75th percentile · In line with own history · Data 2020–2026
Loading P/E history...
P/E Ratio Analysis
As of June 22, 2026, Crescent Capital BDC, Inc. (CCAP) trades at a price-to-earnings ratio of 12.0x, with a stock price of $11.19 and trailing twelve-month earnings per share of $0.41.
The current P/E is 11% below its 5-year average of 13.5x. Over the past five years, CCAP's P/E has ranged from a low of 4.2x to a high of 62.4x, placing the current valuation at the 75th percentile of its historical range.
Compared to the Financial Services sector median P/E of 13.6x, CCAP is roughly in line with its sector peers. The sector includes 783 companies with P/E ratios ranging from 0.0x to 196.5x.
Relative to the broader market, CCAP trades at a notable discount to the S&P 500 median P/E of 24.3x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our CCAP DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
CCAP Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
CCAP P/E vs Peers
Private credit and BDC lenders peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $13B | 9.6 | 0.94 | -24% | |
| $3B | 8.7 | 0.28 | +4% | |
| $898M | 14.3 | - | -46% | |
| $193M | 3.9Lowest | 4.04 | +49%Best | |
| $719M | 10.1 | 1.17 | -49% | |
| $746M | 10.6 | 0.16Best | -36% | |
| $3B | 257.8 | - | -98% | |
| $5B | 8.7 | 1.99 | -19% | |
| $3B | 8.2 | - | +15% | |
| $669M | 7.2 | 0.20 | -3% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
CCAP Historical P/E Data (2020–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q1 | - | $12.15 | $0.41 | 29.6x | +130% |
| FY2025 Q4 | Dec 31 2025 | $14.05 | $1.28 | 11.0x | -15% |
| FY2025 Q3 | - | $14.26 | $1.32 | 10.8x | -16% |
| FY2025 Q2 | Jun 30 2025 | $14.10 | $1.77 | 8.0x | -38% |
| FY2025 Q1 | Mar 31 2025 | $17.12 | $1.91 | 9.0x | -30% |
| FY2024 Q4 | - | $19.22 | $2.22 | 8.7x | -33% |
| FY2024 Q3 | Sep 30 2024 | $18.50 | $2.78 | 6.7x | -48% |
| FY2024 Q2 | Jun 30 2024 | $18.78 | $2.75 | 6.8x | -47% |
| FY2024 Q1 | Mar 31 2024 | $17.26 | $2.81 | 6.1x | -52% |
| FY2023 Q4 | Dec 31 2023 | $17.38 | $2.29 | 7.6x | -41% |
| FY2023 Q3 | Sep 30 2023 | $17.10 | $1.54 | 11.1x | -14% |
| FY2023 Q2 | Jun 30 2023 | $15.14 | $0.86 | 17.7x | +37% |
| FY2023 Q1 | Mar 31 2023 | $13.62 | $0.22 | 62.4x | +384% |
| FY2022 Q4 | Dec 31 2022 | $12.78 | $0.50 | 25.6x | +99% |
| FY2022 Q3 | Sep 30 2022 | $15.02 | $0.87 | 17.2x | +33% |
| FY2022 Q2 | - | $15.50 | $1.54 | 10.1x | -22% |
| FY2022 Q1 | - | $17.80 | $2.73 | 6.5x | -49% |
| FY2021 Q4 | Dec 31 2021 | $17.60 | $2.97 | 5.9x | -54% |
| FY2021 Q3 | - | $19.13 | $3.73 | 5.1x | -60% |
| FY2021 Q2 | Jun 30 2021 | $18.76 | $4.50 | 4.2x | -68% |
| FY2021 Q1 | Mar 31 2021 | $17.18 | $5.34 | 3.2x | -75% |
| FY2020 Q4 | - | $14.57 | $1.74 | 8.4x | -35% |
| FY2020 Q3 | Sep 30 2020 | $12.75 | $0.87 | 14.7x | +14% |
Average P/E for displayed period: 12.9x
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
6+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
CCAP — Frequently Asked Questions
Quick answers to the most common questions about buying CCAP stock.
What is CCAP's P/E ratio?
Crescent Capital BDC, Inc. (CCAP) trailing twelve-month P/E ratio is 12.0x, based on TTM diluted EPS of $0.41. The 5-year average P/E is 13.5x and the historical range spans 4.2x to 62.4x.
Is CCAP stock overvalued or undervalued?
CCAP trades at 12.0x P/E, near its 5-year average of 13.5x. The 75th percentile ranking within the 4.2x–62.4x historical range places valuation within normal bounds.
Is CCAP stock expensive?
CCAP is fairly valued relative to its own history. The current P/E of 12.0x is near the 5-year average of 13.5x (75th percentile of historical range).
What is CCAP's historical P/E range?
Over the past 5 years, CCAP's P/E ratio has ranged from 4.2x to 62.4x, with a median of 9.0x and an average of 13.5x. The current P/E of 12.0x places the stock at the 75th percentile of this range. Full historical data spans 2020–2026.
How does CCAP's P/E compare to the S&P 500?
CCAP trades at 12.0x P/E versus the S&P 500 median of 24.3x. The 51% discount to the market suggests lower growth expectations or perceived higher risk.
How does CCAP's valuation compare to Financial Services peers?
Crescent Capital BDC, Inc. P/E of 12.0x compares to the Financial Services sector median of 13.6x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is CCAP's PEG ratio?
CCAP PEG ratio is N/A, based on a P/E of 12.0x and EPS growth of -53.3%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is CCAP's earnings yield?
CCAP earnings yield is 8.31%, the inverse of its 12.0x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.